June 2026 Cohort
Welcome Week
Here you will find the agenda, information about fellow companies and speakers for the week
Agenda
Monday, July 6
8:30-9:00 a.m.
Breakfast
Two Discovery Square
9:00-10:00 a.m.
Welcome & Company Introductions
Kathy Wendt
10:00-10:45 a.m.
Industry Insights and The Future of Healthcare
Dr. John Halamka (virtual)
10:45-11:00 a.m.
Break
11:00-12:00 p.m.
Mayo Clinic History and Values
Ann Pestorious, M.S., M.A.
12:00-12:30 p.m.
Special Session with the Mayo Clinic Platform Chief Medical Officer
Gelareh Zadeh, M.D., Ph.D.
12:30-1:30 p.m.
Lunch
Two Discovery Square
1:30-4:00 p.m.
Video Shoot/Flex time/B-Roll Footage
(Companies 1-9)
Ambient House Studios
1:30-3:00 p.m.
Group Tour- Mayo Downtown Campus
(Companies 10-18)
Jeff Anderson, Ph.D.
1:30-2:00 p.m.
Perimind (1) / Aquoris (2) Video Shoots
One Discovery Square
2:00-2:30 p.m.
Burna AI (3) / Caremaze (4) Video Shoots
One Discovery Square
2:30-3:00 p.m.
Dr. Data (5) / Healthier (6) Video Shoots
One Discovery Square
3:00-3:30 p.m.
HealMint (7) / Immunara (8) Video Shoots
One Discovery Square
3:30-4:00 p.m.
InformAI (9) Video Shoot
One Discovery Square
4:00-6:00 p.m.
Break
6:00-7:30 p.m.
Dinner
Bleu Duck Kitchen
Tuesday, July 7
8:30-9:00 a.m.
Breakfast
Two Discovery Square
9:00-9:30 a.m.
Group Photo
One Discovery Square (steps)
9:30-10:30 a.m.
Insights from Alumni: The Accelerate Experience (Virtual)
Koroid, Numen, Medlink Global, AiVali
10:30-11:00 a.m.
Program Success Session - Accelerate Team
Two Discovery Square
11:00 a.m.-12:00 p.m.
The Platform Journey
Asia Smith, Kyle Eisenzimmer, Sara Christofferson
12:00-1:00 p.m.
Lunch
Two Discovery Square
1:00-3:00 p.m.
Video Shoot/Flex time/B-Roll Footage
(Companies 11-18)
Ambient House Studios
1:00-2:30 p.m.
Group Tour - Mayo Downtown Campus
(Companies 1-9)
Jeff Anderson, Ph.D.
1:00-1:30 p.m.
Odesso (10) / MICA (11) Video Shoots
One Discovery Square
1:30-2:00 p.m.
Maverick Medical Video Shoot (12)
One Discovery Square
2:00-2:30 p.m.
PrecXIMed Inc (13) / Rette AI (14) Video Shoots
One Discovery Square
2:30-3:00 p.m.
Summit Health (15) / SyncVR (16) Video Shoots
One Discovery Square
3:00-3:30 p.m.
ThinkbioAI (17) / éo vision (18) Video Shoots
One Discovery Square
3:30-5:30 p.m.
Break
5:45 p.m.
Bus Departs from Hotel Indigo Lobby
Hotel Indigo
6:00-8:00 p.m.
Dinner
Mayowood Mansion
Wednesday, July 8
8:30-9:00 a.m.
Breakfast
Two Discovery Square
9:30-10:00 a.m.
Medical Alley
Ben Wagner
10:00-11:00 a.m.
Mayo Clinic Business Development/DMC
Geof Hannigan
11:00-11:30 a.m.
Innovation Exchange
Brian Kilen
11:30-11:45 a.m.
Closing
Accelerate Team
Meet the companies:
Aquoris Intelligence is building Vega, a clinical reasoning platform designed to support physicians during moments of diagnostic uncertainty. Vega helps clinicians think through complex cases, differential diagnoses, treatment considerations, and longitudinal patient context using AI-assisted reasoning rather than simple information retrieval. Aquoris is focused on developing safe, physician-centered clinical reasoning infrastructure that augments—not replaces—medical professionals, with the long-term vision of creating a globally scalable reasoning layer for healthcare systems.
Burna grades adverse events with the evidence attached and ships both the CTCAE grade and the MedDRA LLT code on every encounter, from clinical trials through postmarket surveillance. Site queries resolve on first read. Trials close on time. The downstream is better cancer care, for every patient.
Cardiolife is a healthcare technology company providing a cloud-based, AI-powered platform for automated interpretation of resting ECG and Holter recordings. Designed to help clinicians manage growing diagnostic volumes, the platform delivers fast, consistent, and clinically validated cardiac analysis while integrating seamlessly into existing healthcare workflows and IT systems. Cardiolife is device-agnostic and regulatory-ready, enabling healthcare providers to deploy advanced ECG analytics across diverse clinical settings. By supporting earlier detection of cardiovascular conditions and improving operational efficiency, Cardiolife helps healthcare systems deliver high-quality cardiac care at scale.
Caremaze is an AI-powered discharge coordination platform for hospitals that reduces length of stay, lowers coordination burden, and gives clinical teams more time for patient care. Caremaze surfaces barriers before they delay discharge, then tracks, assigns, and orchestrates tasks across systems so nothing falls through the cracks. Built with clinical leaders from top academic medical centers, it brings every patient, blocker, and next step into one unified view for physicians, nurses, case managers, and leadership. With human-in-the-loop safeguards, AI suggests and staff decide, with every recommendation grounded in EMR data
Dr. Data Inc. builds the decision layer for evidence-grounded cardiovascular AI. Its APEX platform orchestrates specialized AI agents that fuse clinical guidelines, angiographic imaging, patient-matched digital twins, and real-world cohort analytics into a single auditable consensus report for the heart team. This ensures every recommendation is traceable to verified data—improving the accuracy, consistency, and defensibility of cardiovascular treatment decisions while reducing variability across clinicians and sites and laying the foundation for standardized, evidence-aligned care at scale.
There is information in every medical image that doctors cannot see. Its absence drives much of the ~1M lives lost and $100B wasted in the system each year.
éo extracts that unread signal, the information behind medicine's most expensive decisions. Then we build a market around it, selling it to the hospitals, insurers, and drug developers who carry those losses today.
HealMint unifies a multimodal AI platform and clinical-grade smart devices to transform fragmented health data into predictive intelligence. We empower providers and payers to deliver proactive, real-time care that keeps high-risk patients safe, healthy, and out of the hospital. By seamlessly integrating advanced medical LLMs with continuous biometric tracking, our ecosystem bridges the gap between daily life and clinical intervention. HealMint catches critical health shifts before they become emergencies, streamlining workflows for clinicians while lowering overall costs for healthcare systems. We are building the foundational infrastructure for the future of continuous, autonomous, and truly preventative patient care worldwide.
Healthier Intelligence is building an AI-native clinical reasoning engine for healthcare, starting with oncology. Its platform ingests fragmented medical records, labs, imaging, genomics, guidelines, literature, and clinical-trial protocols, then turns them into source-grounded briefs that patients can understand and clinicians can review. Healthier’s products include a Patient Companion, an AI Oncology Fellow for clinicians, and AI-assisted Tumor Board / Second Opinion workflows for complex cases. The company’s mission is to raise the quality of every healthcare decision by giving patients and providers access to shared, trusted, clinically rigorous reasoning.
Immunara is an AI biology lab working on precision immunology. We build biological foundation models to deeply understand immune-mediated disease, revealing patterns in biology that have been invisible to conventional approaches. We generate and aggregate multiomic & clinical data in partnership with leading academic medical centers and pharmaceutical companies, and turn it into biological insight and clinical impact.
InformAI is a technology company dedicated to advancing healthcare through AI clinical solutions. The company specializes in creating sophisticated products for oncology and diagnostic imaging to improve patient outcomes. They leverage strong partnerships to deliver impactful solutions in large and fast-growing markets.
Their flagship product, RadOncAI, accelerates radiation therapy dose planning workflows and enhances clinical treatment decisions. The RadOncAI radiation therapy product generates radiation dose plans in minutes compared to what currently takes 6 – 24 hours to complete. This product is now the standard of care used in treating cancer patients at a premier cancer center.
Maverick Medical AI delivers a real-time autonomous medical coding and revenue integrity platform that helps providers improve documentation at the point of care, prevent denials, reduce addenda, automate coding workflows, and accelerate reimbursement with proprietary AI models operating at scale.
MICA Artificial Intelligence Ltd. is a health-tech and radiology AI startup based in Tel Aviv, developing M2C - an advanced, AI-based solution for breast cancer detection in women with dense breast tissue. M2C eliminates the need for contrast-enhanced mammography (CEM), MRI, and ultrasound for breast cancer detection, while seamlessly integrating into standard mammography workflows. MICA’s technology leverages proprietary computer vision algorithms to improve detection rates, reduce pain, radiation exposure, and healthcare costs, and save valuable radiologists’ time through more efficient and accurate diagnostic interpretation.
Odesso is a premier clinical AI and intelligent automation platform purpose-built for healthcare organizations navigating value-based care. Trusted by national provider networks and ACOs, Odesso delivers proven 98%+ accuracy in autonomously extracting ICD-10, CPT, and HCC codes from complex clinical notes. By seamlessly integrating with existing EMRs and billing systems, the platform proactively identifies missed risk conditions, closes care gaps, and visualizes quality performance in real time. Odesso’s comprehensive suite eliminates manual workflows by over 50%, ensures audit-ready compliance, and empowers organizations to capture hidden revenue, boost Stars ratings, and scale clinical operations with unmatched speed and precision
Perimind is an AI operative revenue optimization platform, founded by physicians and Princeton engineers. Our AI anesthesiologist delivers real-time intra-operative decision support for anesthesiologists. Our revenue optimization engine converts operative notes into accurate CPT codes and wRVUs/collections, maximizing revenue collection for medical practices. Built by surgeons, anesthesiologists, and engineers, PeriMind is a groundbreaking tool to improve perioperative productivity, safety, and revenue collection.
Plexis AI is the governed execution layer for hospitals adopting AI agents. It connects EHRs, lab systems, scheduling, ERP, messaging, and internal tools, then turns AI-agent recommendations and system events into secure, auditable operational workflows without exposing hospitals to unmanaged automation risk. As healthcare moves beyond AI copilots and dashboards, Plexis enables organizations to convert signals into coordinated follow-through across existing infrastructure.
PrecXIMed is building an AI-powered brain tumor care platform that closes the coordination gap in neuro-oncology by connecting imaging interpretation, surgical planning, and remote postoperative monitoring into a single continuous workflow. The platform segments brain tumors from scans, translates imaging findings into surgeon-ready insights, and integrates imaging and clinical data to support surgical risk prediction. After discharge, patients are continuously monitored through neurological symptoms and vital signs, enabling earlier detection of deterioration and more proactive intervention by care teams. PrecXIMed aims to reduce avoidable complications and readmissions, and help neuro-oncology teams deliver more proactive, data-driven care that improves patient outcomes.
Rette is an AI-driven clinical intelligence platform that automates high-complexity orthopedic revenue cycle workflows. It uses a Hybrid Agentic Architecture, leveraging large language models for advanced clinical reasoning and traditional NLP models for high-precision, deterministic validation. This dual-layer "Defect Detection Engine" interprets complex orthopedic intent from unstructured operative narratives—capturing implant identifiers, laterality, defect flags, and procedural modifiers—while reconciling every documented action against structured clinical data and financial records. By surfacing the documentation gaps that drive denials, peer-to-peer reviews, and surgeon burnout, Rette aligns clinical detail with real-world billing rules. Built for regulated, auditable environments, it validates against clinician-adjudicated ground truth.
Summit Health Data automates clinical data abstraction and brings quantum-enhanced analytics to bone marrow transplant and cellular therapy programs. Our AI-powered platform extracts data from source documents and maps it to registry forms, clinical trial electronic data capture systems, and databases – cutting manual abstraction and duplicate entry by 80%. Summit’s quantum-enhanced analytics surface real-time insights that advance patient outcomes and survival, while delivering high-quality predictions for clinical trials that accelerate novel therapies. Built by transplant data managers who spent years doing this by hand and leaders in quantum technology, Summit delivers insights so clinical teams can focus on patient care.
SyncVR Medical is improving patient outcomes by scaling immersive care across entire health systems. As Europe's largest XR healthcare provider, they unburden clinical teams with their intuitive Treatment Manager: a bedside interface giving one-click access to validated apps. Their flagship XR software, Relax & Distract, is already proven to reduce procedural anxiety and pain across 250 global institutions. By unifying the fragmented XR market into a single ecosystem, SyncVR helps hospitals improve staff efficiency and patient outcomes.
ThinkBio.Ai® is an AI-driven biology company focused on bridging laboratory discoveries and patient care. It converts complex biological and clinical data - including genomics, transcriptomics, proteomics, metabolomics, and phenomics -into clear, actionable insights using advanced AI and biological expertise. The company's knowledge-driven platforms help biopharma and healthcare organizations accelerate drug development, lower costs, and improve patient outcomes. By integrating real-world evidence with knowledge-driven tools, it supports faster, more confident decision-making. Headquartered in California with offices in London and India, the company employs 400+ clinicians, scientists, and engineers dedicated to advancing the company’s vision.
Meet the speakers:
John D. Halamka, M.D., M.S.,
Dwight and Dian Diercks President, Mayo Clinic Platform
John D. Halamka, M.D., M.S., the Dwight and Dian Diercks President, Mayo Clinic Platform, and Michael D. Brennan, M.D., President's Strategic Initiative Professor, brings together solution developers, data partners and healthcare service providers to transform healthcare. Trained in emergency medicine and medical informatics, Dr. Halamka has been developing and implementing healthcare information strategy and policy for more than 25 years.
Prior to his appointment at Mayo Clinic, he was chief information officer at Beth Israel Deaconess Medical Center, where he served governments, academia and industry worldwide. As the International Healthcare Innovation Professor at Harvard Medical School, Dr. Halamka helped the George W. Bush administration, the Obama administration and governments around the world plan their healthcare information strategies.
Gelareh Zadeh, M.D., Ph.D.
David C. and Flora C. Pratt Distinguished Chief Medical Officer, Mayo Clinic Platform
Gelareh Zadeh, M.D., Ph.D., is the David C. and Flora C. Pratt Distinguished Chief Medical Officer, Mayo Clinic Platform, and a Professor and Chair of the Department of Neurologic Surgery at Mayo Clinic in Rochester. Dr. Zadeh’s research focuses on integrated multiplatform molecular analysis of brain tumors, together with a focus on understanding molecular response to targeted therapies, such as anti-angiogenesis and metabolic inhibitors. Her seminal research also focuses on use of circulating biomarkers for detection, diagnosis and discrimination in outcomes of brain tumors. She has consistent peer-reviewed funding from the National Institutes of Health, the Canadian Institutes of Health Research, the Department of Defense, the Canadian Cancer Society, the Brain Canada Foundation, among others. She helps guide Mayo Clinic Platform’s clinical strategy and collaborations to accelerate innovation that benefits patients.
Ann Pestorious, M.S., M.A.
Manager Human Resources, Mayo Clinic
Ann Pestorious is the Coordinator for the Mayo Clinic Values Council. She holds the rank of Instructor in Health Care Administration in the College of Medicine and is a fellow in the Academy of Educational Excellence. She has a Master’s Degree in Organizational Management and a Master’s Degree in Education. Ann began her career as a staff development specialist at a Mayo Clinic Health System site where she was a regional administrator for the learning management system and an instructional designer for online and classroom education. She joined the Program in Professionalism and Values in 2014 as a senior instruction design specialist and served as the chair of the Mayo Clinic Values Council Education Committee. In 2022 she moved into her current role as Coordinator and supports all of the work of the Values Council including education, research and recognition.
Jeff Anderson, Ph.D., M.B.A.
Director of Accounts Solution Developer Market, Mayo Clinic Platform
Jeff Anderson, Ph.D., M.B.A., is the Director of the Solution Developer Account Management group at Mayo Clinic Platform. In that role, he and his team seek to enable the success of the Solution Developer companies on Mayo Clinic Platform as they create, improve, validate, and, through the Solutions Studio program, go to market with AI-driven healthcare solutions with the ultimate shared goal of transforming healthcare together. Dr. Anderson has been at Mayo since 2015, has worked within Mayo’s Center for Clinical and Translational Science and Mayo’s technology transfer group Mayo Clinic Ventures, and has been with Mayo Clinic Platform since its inception in 2019. Before coming to Mayo, Dr. Anderson was engaged in research at Houston Methodist Research Institute. His PhD in Physical Chemistry was carried out at Washington University in St. Louis. Dr. Anderson also trained as a Postdoc in the Advanced Imaging Research Center at UT Southwestern Medical Center where he was an American Diabetes Association Postdoctoral Fellow. Dr. Anderson received his MBA from the Labovitz School of Business and Economics at the University of Minnesota Duluth and is a registered Patent Agent with the USPTO. Outside of work, Jeff’s favorite “hobby” is his family; he is the proud father of six children.
Sara Christofferson, M.S.
Client Relationship Manager, Mayo Clinic Platform
Sara Christofferson, M.S., operations administrator, Mayo Clinic, is responsible for multiple Mayo Clinic Care Network client relationships and works closely with internal and external colleagues to strengthen clinical collaboration between health care organizations. In addition to her account management responsibilities, she supports cancer service line activities for domestic care network members. This work enhances connections in cancer care to better serve providers and patients. Christofferson was integral in developing Mayo Clinic eBoards. eBoards offer both Mayo Clinic and care network providers a collegial, multidisciplinary forum to discuss patients with challenging and complex disease.
Christofferson joined Mayo Clinic in 2008. In addition to her work with the Mayo Clinic Care Network, she has served in the role of a continuing medical education specialist for the Department of Radiology. Prior to joining Mayo Clinic, she taught English and communication studies at Mayo High School in Rochester, Minnesota. After receiving her undergraduate degree from St. Cloud State University, Christofferson earned her master’s degree in educational leadership/administration.
Asia Smith, M.P.H.
Program Success Manager, Accelerate
Mayo Clinic Platform
Asia Smith, M.P.H. is a Program Success Manager with the Mayo Clinic Platform_Accelerate program, where she leads application review, interviews, proposal evaluation, and due diligence to advance high-impact healthcare AI companies through pre-contracting. She brings prior experience in technology development and intellectual property review at Mayo Clinic. Asia also serves as a Captain in the U.S. Army Reserve as a hospital administrator.
Kyle Eisenzimmer
Sales Account Manager, Mayo Clinic Platform
Kyle Eisenzimmer is a strategic leader at Mayo Clinic Platform, where he plays a key role in advancing the organization's mission to transform healthcare through data-driven innovation, scalable technology, and collaborative partnerships. With a strong background in health technology and digital transformation, Kyle helps bridge clinical expertise with cutting-edge platforms to improve patient outcomes and unlock the potential of AI and data analytics in medicine.
Brian Kilen
Principal Business Strategist, Mayo Clinic
Brian Kilen is the principal business strategist for the Mayo Clinic Innovation Exchange. He has a wide set of experiences in healthcare, product management, and innovation development. He has found a home at Mayo Clinic for nearly fifteen years, where he has developed strategic plans for everything from international market entry to innovative healthcare practices. He holds a soft spot for the role of laboratory diagnostics in healthcare. He credits Mayo Clinic for teaching him that innovation must be rooted in values. Brian holds a Juris Doctorate and an undergraduate degree in philosophy.
Geof Hannigan, PhD
Senior Business Development Manager, Destination Medical Center, Mayo Clinic
Dr. Geof Hannigan is currently a senior manager for Mayo Clinic Destination Medical Center. Prior to joining Mayo Clinic, Dr. Hannigan was a principal for Medical Alley in Minnesota, where he designed and launched a popular, recurring Startup Education Bootcamp. He has also led innovation and startup acceleration programs at Merck and other organizations. His work in biopharma, computational biology, and machine learning has driven digital innovation, scientific entrepreneurship, and R&D programs that have advanced drug discovery and healthcare technology.